(Q36726710)

15 August 2017

1 reference

title

Processing and assembly of the dystrophin glycoprotein complex (English)

1 reference

15 August 2017

Michael J Allikian

1

1 reference

PubMed ID

17274800

15 August 2017

Elizabeth M McNally

series ordinal

2

1 reference

15 August 2017

26 January 2007

1 reference

15 August 2017

1 reference

15 August 2017

8

1 reference

15 August 2017

3

1 reference

15 August 2017

177-183

1 reference

Molecular organization of sarcoglycan complex in mouse myotubes in culture

15 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

From dystrophinopathy to sarcoglycanopathy: evolution of a concept of muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Biochemical evidence for association of dystrobrevin with the sarcoglycan-sarcospan complex as a basis for understanding sarcoglycanopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Costameres: the Achilles' heel of Herculean muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Membrane organization of the dystrophin-glycoprotein complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Beta-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the delta-sarcoglycan gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Mutations in the dystrophin-associated protein gamma-sarcoglycan in chromosome 13 muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Gamma-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Loss of the sarcoglycan complex and sarcospan leads to muscular dystrophy in beta-sarcoglycan-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Sarcoglycan isoforms in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Expression of Dp260 in muscle tethers the actin cytoskeleton to the dystrophin-glycoprotein complex and partially prevents dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

New insights in the regulation of calcium transfers by muscle dystrophin-based cytoskeleton: implications in DMD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Identification of functional domains in sarcoglycans essential for their interaction and plasma membrane targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Specific assembly pathway of sarcoglycans is dependent on beta- and delta-sarcoglycan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Enrichment of the R77C alpha-sarcoglycan gene mutation in Finnish LGMD2D patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Alpha-sarcoglycan is recycled from the plasma membrane in the absence of sarcoglycan complex assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

The beta-delta-core of sarcoglycan is essential for deposition at the plasma membrane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Molecular recognition by LARGE is essential for expression of functional dystroglycan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Mechanisms of disease: congenital muscular dystrophies-glycosylation takes center stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Dystroglycan: from biosynthesis to pathogenesis of human disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Inhibition of dystroglycan cleavage causes muscular dystrophy in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Transgenic expression of {alpha}7{beta}1 integrin maintains muscle integrity, increases regenerative capacity, promotes hypertrophy, and reduces cardiomyopathy in dystrophic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Transgenic overexpression of dystroglycan does not inhibit muscular dystrophy in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

The effects of post-translational processing on dystroglycan synthesis and trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve alpha-dystroglycan. The role of a novel O-mannosyl-type oligosaccharide in the binding of alpha-dystroglycan with laminin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Glycosylation in congenital muscular dystrophies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Glycobiology of neuromuscular disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Overexpression of the cytotoxic T cell GalNAc transferase in skeletal muscle inhibits muscular dystrophy in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Developmental expression of sarcoglycan gene products in cultured myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Formation of sarcoglycan complex with differentiation in cultured myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Filamin 2 (FLN2): A muscle-specific sarcoglycan interacting protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Calpain 3 is activated through autolysis within the active site and lyses sarcomeric and sarcolemmal components

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Calpain 3 cleaves filamin C and regulates its ability to interact with gamma- and delta-sarcoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

A mutation in the dimerization domain of filamin c causes a novel type of autosomal dominant myofibrillar myopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Loss of FilaminC (FLNc) results in severe defects in myogenesis and myotube structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Biglycan binds to alpha- and gamma-sarcoglycan and regulates their expression during development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

The small leucine-rich repeat proteoglycan biglycan binds to alpha-dystroglycan and is upregulated in dystrophic muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Decorin and biglycan expression is differentially altered in several muscular dystrophies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Molecular and genetic characterization of sarcospan: insights into sarcoglycan-sarcospan interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Membrane targeting and stabilization of sarcospan is mediated by the sarcoglycan subcomplex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Sarcospan-deficient mice maintain normal muscle function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Loss of sarcolemma nNOS in sarcoglycan-deficient muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

Hypertrophic response of Duchenne and limb-girdle muscular dystrophies is associated with activation of Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

A role for the lissencephaly gene LIS1 in mitosis and cytoplasmic dynein function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

The role of cytoplasmic dynein in the human brain developmental disease lissencephaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0854.2006.00519.X

10.1111/J.1600-0854.2006.00519.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17274800